User: Guest

NANOBIOTECHNOLOGY

Global Market Trajectory & Analytics

MCP-1476

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

4747
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

854
Interactions with Platform & by Email

PARTICIPANTS

142
Unique # Participated

VALIDATIONS

64
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

SEPTEMBER 2020

TABLES

54

PAGES

163

EDITION

17

PRICE

USD $5600


Amid the COVID-19 crisis, the global market for Nanobiotechnology estimated at US$62.3 Billion in the year 2020, is projected to reach a revised size of US$100.8 Billion by 2027, growing at aCAGR of 7.1% over the period 2020-2027. Pharmaceuticals & Biotechnology Industry, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$68.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Medical Devices segment is readjusted to a revised 6% CAGR for the next 7-year period.
The Nanobiotechnology market in the U.S. is estimated at US$18.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$17.6 Billion by the year 2027 trailing a CAGR of 6.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.7% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.We bring years of research experience to this 17th edition of our report. The 163-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Ablynx NV; Arrowhead Pharmaceuticals Inc.; CaPtivate Pharmaceuticals LLC; Celgene Corporation; ELITechGroup; Flamel Technologies SA; GlaxoSmithKline Plc; Johnson & Johnson; Merck & Co. Inc.; NanoBio® Corporation; Nanophase Technologies Corporation; pSivida Corp.; Sigma-Aldrich Corp.; Starpharma Holdings Ltd.; Vectura Group plc
» End-Use (Pharmaceuticals & Biotechnology Industry, Medical Devices)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
A Curtain Raiser
Recent Market Activity
Nanobiotechnology - The Next Big Thing
An Insight into the Global Nanobiotechnology Market
Major Market Drivers
Where Conventional Molecular Science Falls Short…Nanobio Steps In
Nanotechnology Revolutionizes Pharmaceuticals & Healthcare Sector
Nanomedicine Market to Achieve Phenomenal Growth
Opportunities Galore for Nanomedicine
Drug Delivery - A Promising Application Area for Nanotechnology
Nanotechnology Offers Huge Potential in Brain Disorder Treatment
High Demand for Nanobots and Nano Healthcare Devices
Nanotechnology Gaining Prominence for Treatment of Cancer
Nanotechnology in Drug Delivery: A Specialized Market Opportunity
Commercialization of Nanotechnology-based Medical Products Gains Momentum
Nanodiagnostic Products to Witness Strong Demand Growth
Dendrimers Serve as a Base to Build Multifunctional Nanodevices
Nanotechnology Rescues Poor Water Soluble Drugs from Abandonment
Huge Opportunities for Nanomaterials in the Medical Field
Commercial Opportunities in Healthcare Sector
Future Possibilities
Global Market for Fullerenes - An Insight
Dawn Breaks on Nanobiotechnology
Demystifying the Intriguing World of Nanobiotech
A Meeting Place of Medicine’s Best Solutions
Nanobiotechnology to Become Viable for All Drug Development Stages
Nanoparticles: The Foundation of Nanobiotechnology
Improved Optical Properties and Stability of Nanoparticles
Nanoemulsions
The Promise of Nanobiotechnology
Biological Weaponries against Diseases Come in Small Packages
Proffered Benefits of Nanobiotechnology
Opportunity & Beyond
Nanobiotechnology - Will it Live Up to the Expectations?
The Future of Nanobiotechnology: Shape of Things to Come
Nanobiotechnology: The Outer Limits
Futuristics: A Rumination
Conclusions
Global Competitor Market Shares
Nanobiotechnology Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Ablynx NV (Belgium)
Arrowhead Pharmaceuticals, Inc. (USA)
Avadel Pharmaceuticals plc (Ireland)
CaPtivate Pharmaceuticals LLC (USA)
Celgene Corporation (USA)
ELITechGroup (France)
GlaxoSmithKline Plc. (UK)
Johnson & Johnson (USA)
Merck & Co., Inc. (USA)
NanoBio® Corporation (USA)
Nanophase Technologies Corporation (USA)
pSivida Corp. (USA)
Sigma-Aldrich Corp. (USA)
Starpharma Holdings Ltd. (Australia)
Vectura Group plc (UK)
3. MARKET TRENDS & DRIVERS
Present Status and Future Opportunities
Outlook
Developing Countries to Rise over the Horizon
Nanomaterials & Nanoparticles Witness Robust Activity
Focus on Improved Performance to Bring New Manufacturing Methods for Nanomaterials
Why Invest in Nanobiotechnology?
Private and Public Companies to Step Up Funding on Nanotechnology
United States Lead the Way in Government Funding
Increasing Awareness on Technology to Drive Growth
Demand for Novel Products to Push Up Growth
Nano-Enabled Drug Discovery Holds Tremendous Potential
Consolidation Sharpens the Industry's Edge
The Regulatory Framework Evolves with the Technology
Quantum Dot Patents Pose Legal Tangles
Miniaturized Liquid Handling Becomes Progressive
Trends in Nanotechnology Enabled Drug Delivery Systems
Patent Expiries: A Key Driver
Nanotechnology Enabled Drug Delivery to Exhume Unused Drugs
4. GLOBAL MARKET PERSPECTIVE
Nanobiotechnology Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Nanobiotechnology Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
Nanobiotechnology Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
Pharmaceuticals & Biotechnology Industry (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
Pharmaceuticals & Biotechnology Industry (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
Pharmaceuticals & Biotechnology Industry (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
Medical Devices (End-Use) Worldwide Sales in US$ Million by Region/Country: 2018-2025
Medical Devices (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017
Medical Devices (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
GEOGRAPHIC MARKET ANALYSIS
United States
Market Facts & Figures
US Nanobiotechnology Market Share (in %) by Company: 2018 & 2025
United States Nanobiotechnology Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
Nanobiotechnology Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017
Nanobiotechnology Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025
Canada
Canadian Nanobiotechnology Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
Nanobiotechnology Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
Canadian Nanobiotechnology Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
Japan
Japanese Demand Estimates and Forecasts for Nanobiotechnology in US$ Million by End-Use: 2018 to 2025
Japanese Nanobiotechnology Market in US$ Million by End-Use: 2009-2017
Nanobiotechnology Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025
China
Chinese Demand for Nanobiotechnology in US$ Million by End-Use: 2018 to 2025
Nanobiotechnology Market Review in China in US$ Million by End-Use: 2009-2017
Chinese Nanobiotechnology Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
Europe
Market Facts & Figures
European Nanobiotechnology Market: Competitor Market Share Scenario (in %) for 2018 & 2025
European Nanobiotechnology Market Demand Scenario in US$ Million by Region/Country: 2018-2025
Nanobiotechnology Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
European Nanobiotechnology Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
European Nanobiotechnology Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
Nanobiotechnology Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
European Nanobiotechnology Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
France
Nanobiotechnology Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025
French Nanobiotechnology Historic Market Review in US$ Million by End-Use: 2009-2017
French Nanobiotechnology Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
Germany
Nanobiotechnology Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
German Nanobiotechnology Market in Retrospect in US$ Million by End-Use: 2009-2017
Nanobiotechnology Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025
Italy
Italian Demand for Nanobiotechnology in US$ Million by End-Use: 2018 to 2025
Nanobiotechnology Market Review in Italy in US$ Million by End-Use: 2009-2017
Italian Nanobiotechnology Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
United Kingdom
United Kingdom Demand Estimates and Forecasts for Nanobiotechnology in US$ Million by End-Use: 2018 to 2025
United Kingdom Nanobiotechnology Market in US$ Million by End-Use: 2009-2017
Nanobiotechnology Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025
Rest of Europe
Rest of Europe Nanobiotechnology Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
Nanobiotechnology Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
Rest of Europe Nanobiotechnology Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
Asia-Pacific
Nanobiotechnology Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
Asia-Pacific Nanobiotechnology Historic Market Review in US$ Million by End-Use: 2009-2017
Asia-Pacific Nanobiotechnology Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
Rest of World
Rest of World Nanobiotechnology Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
Nanobiotechnology Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
Rest of World Nanobiotechnology Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
Total Companies Profiled : 80

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com